Cost Effective Analysis | List of Frontiers open access articles

Original Research

Published on 22 Aug 2025

Cost-effective analysis of sugemalimab plus chemotherapy as first-line treatment for advanced gastric or gastroesophageal junction adenocarcinoma with PD-L1 CPS ≥5

in Health Economics

Yalan Zhang
Ying He
Ruijia Chen
Maojin You

Frontiers in Public Health

doi 10.3389/fpubh.2025.1604372

2,684 views
2 citations

Methods

Published on 11 Aug 2022

Rapid and simple analysis of short and long sequencing reads using DuesselporeTM

in Computational Genomics

Christian Vogeley
Thach Nguyen
Selina Woeste
Jean Krutmann
Thomas Haarmann-Stemmann
Andrea Rossi

Frontiers in Genetics

doi 10.3389/fgene.2022.931996

4,463 views
3 citations

Original Research

Published on 03 Dec 2021

Cost-Effectiveness of Portable Electrocardiogram for Screening Cardiovascular Diseases at a Primary Health Center in Ahmedabad District, India

in Health Economics

Komal Shah
Apurvakumar Pandya
Priya Kotwani
Somen Saha
Chintan Desai
Kirti Tyagi
Deepak Saxena
Tapasvi Puwar
Shilpa Gaidhane

Frontiers in Public Health

doi 10.3389/fpubh.2021.753443

8,221 views
14 citations

Original Research

Published on 05 Aug 2020

The Association Between Previous TORCH Infections and Pregnancy and Neonatal Outcomes in IVF/ICSI-ET: A Retrospective Cohort Study

in Reproduction

Yifeng Liu
Yiqing Wu
Feixia Wang
Siwen Wang
Wei Zhao
Lifen Chen
Shijiong Tu
Yuli Qian
Yun Liao
Yun Huang

Frontiers in Endocrinology

doi 10.3389/fendo.2020.00466

14,058 views
14 citations

Review

Published on 12 Jun 2025

A systematic review of sensors to combat crime and routes to further sensor development

in Analytical Chemistry

Alice E. Cozens
Shane D. Johnson
Tung-Chun Lee

Frontiers in Chemistry

doi 10.3389/fchem.2025.1568867

7,863 views
2 citations

Systematic Review

Published on 13 Dec 2022

Cost-effectiveness of janus kinase inhibitors for rheumatoid arthritis: A systematic review and meta-analysis of cost-utility studies

in Drugs Outcomes Research and Policies

S. Sajith Kumar
Madhumitha Haridoss
Krishnamurthy Venkataraman
Bhavani Shankara Bagepally

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1090361

6,782 views
9 citations

Original Research

Published on 01 Dec 2021

The Livebirth Rate Per In Vitro Fertilization Cycle Is Higher Than The Cumulative Live Birth Rates of Intrauterine Insemination for Patients of Poseidon Group 3 With Unexplained Infertility

in Reproduction

Yixuan Wu
Haiying Liu
Jianqiao Liu

Frontiers in Endocrinology

doi 10.3389/fendo.2021.768975

6,786 views
11 citations

Articles

Cost-effective analysis of sugemalimab plus chemotherapy as first-line treatment for advanced gastric or gastroesophageal junction adenocarcinoma with PD-L1 CPS ≥5

Rapid and simple analysis of short and long sequencing reads using DuesselporeTM

Cost-Effectiveness of Portable Electrocardiogram for Screening Cardiovascular Diseases at a Primary Health Center in Ahmedabad District, India

The Association Between Previous TORCH Infections and Pregnancy and Neonatal Outcomes in IVF/ICSI-ET: A Retrospective Cohort Study

A systematic review of sensors to combat crime and routes to further sensor development

Cost-effectiveness of janus kinase inhibitors for rheumatoid arthritis: A systematic review and meta-analysis of cost-utility studies

The Livebirth Rate Per In Vitro Fertilization Cycle Is Higher Than The Cumulative Live Birth Rates of Intrauterine Insemination for Patients of Poseidon Group 3 With Unexplained Infertility